Let me understand this correctly... you want a finance / business analyst to comment on the FDA recent approval of a drug trial (based solely on safety, not efficacy)?
From a medical point of view? From a financial point of view? From a humanitarian point of view? What could you possibly hope to achieve with this "invitation to comment"?
It's pretty simple analysis:
Medically: it's safe (let's hope it's also effective)
Financial: Were not funding the trial - thank god
Humanitarian: Hope it works out for those poor kids.
invitation to madamanswer to comment, page-2
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.058(5.04%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $7.526M | 6.698M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 150639 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 7879 | 5 |
View Market Depth
| Last trade - 15.32pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |